ClinicalTrials.Veeva

Menu

Palliative Care Yields Cancer Wellbeing Support (Pal-Cycles)

R

Radboud University Medical Center

Status

Enrolling

Conditions

Cancer

Treatments

Procedure: A transitional palliative care intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06259136
101057243

Details and patient eligibility

About

The goal of this study is to evaluate the effectiveness of a programme for transitional palliative cancer care (Pal-Cycles) in seven countries (the Netherlands, Germany, United Kingdom, Hungary, Poland, Romania and Portugal) and its consequent effects on the number of readmissions into hospital.

The main hypothesis for the study is: that fewer people in the intervention arm of the study will require hospital re admission than those having usual care.

Participants will be asked to fill in questionnaires regarding their quality of care and quality of life.

Full description

The study described in this protocol, a stepped wedge clinical trial, is part of a larger research project named: The Palliative Care Yields Cancer Wellbeing Support Programme (Pal-Cycles). The aim is to test and evaluate the implementation of the Pal-Cycles intervention, by implementing it in 14 care setting across seven European countries (the Netherlands, Germany, United Kingdom, Poland, Hungary, Romania and Portugal.) The primary focus of the evaluation will be on measuring the effect of the Pal Cycles intervention using the number of patients being readmitted into hospital after they had transferred to community care in comparison with patients receiving usual care. Additional relevant outcomes will also be gathered and analysed such as: the patient's quality of life, the experience from the family carer and the experience from the healthcare professional. Finally, an economic analysis will be embedded in the stepped wedge design.

The goals of the overarching research project are as follows:

  1. To develop, implement and evaluate a transitional palliative cancer care intervention, with an intervention (the Pal-Cycles intervention) that aims for a smooth transition from the hospital to community-based care in the final months of life.
  2. Adaptation of the transitional palliative cancer care intervention for patients with advanced cancer for its implementation in seven European countries within the project.
  3. Training of oncologists in identifying patients with palliative care needs, establishing collaboratively comprehensive treatment and care plans, delivering patient-centred communication around discharge planning, advance care planning, and end-of-life care.
  4. A clinical trial using a stepped wedge design will be implemented in fourteen care settingsacross seven European countries.
  5. An implementation support intervention will guide the implementation of the clinical trial in all settings and will investigate barriers and opportunities for implementation and provide tailormade solutions where needed.
  6. Dissemination of project results.

Enrollment

1,050 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years or above
  • Patients diagnosed with advanced cancer
  • Patients that are expected to develop or already may have palliative care needs
  • Patients who are in transition from curative (hospital) to palliative care (community care)

Exclusion criteria

  • People with cancer unable or unwilling to provide consent to participate in the study

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

1,050 participants in 2 patient groups

Pal-Cycles Intervention
Experimental group
Description:
The patients in the intervention arm will be exposed to the Pal-Cycles intervention.
Treatment:
Procedure: A transitional palliative care intervention
Care as usual
No Intervention group
Description:
The patients included in this intervention will be given care as usual.

Trial contacts and locations

1

Loading...

Central trial contact

Pippa van den Brand, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems